By accessing glpagonists.com, you agree to be bound by these Terms of Service. If you do not agree, please do not use this site.
GLP Agonists is an editorial publication that reviews and compares GLP-1 telehealth providers. We are not a medical provider, healthcare facility, pharmacy, or telehealth platform. We do not prescribe medications, dispense medications, provide diagnoses, or establish doctor-patient relationships.
Content on this site is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendation. Reading anything on this site does not establish a physician-patient relationship between you and GLP Agonists or its writers.
If you are considering GLP-1 medications or any other treatment, you should consult a licensed physician who can evaluate your individual medical situation. Decisions about your health should be made in partnership with your medical provider — not based on what you read here.
This site is reader-funded through affiliate commissions. When you click certain links on the site (marked with rel="sponsored") and subsequently sign up with the linked provider, we may receive a commission. This relationship is governed by our affiliate disclosure.
Per our editorial standards, affiliate relationships do not influence our rankings, scoring, or coverage decisions. The methodology applied to all providers is the same and is published in full at /methodology.html.
We make reasonable efforts to ensure the accuracy of pricing, regulatory, and clinical information presented on the site. However, the GLP-1 telehealth market changes rapidly. Pricing changes frequently, regulations evolve, and providers come and go. We recommend confirming current pricing and program details directly with the provider before making any decisions.
If you find an error on the site, please email glpagonists@gmail.com with the subject line "Correction request." We commit to evaluating all corrections received and updating the site within 7 business days when warranted.
To the maximum extent permitted by law, GLP Agonists, its writers, editors, and operators are not liable for any direct, indirect, incidental, consequential, or punitive damages arising from your use of this site or reliance on its content. This includes — without limitation — damages arising from medical decisions made based on site content, financial decisions related to choosing a telehealth provider, or any side effects, treatment outcomes, or adverse events related to medications discussed on the site.
This site contains links to third-party websites including telehealth providers, regulatory authorities, scientific publications, and news sources. We do not control these third-party sites and are not responsible for their content, accuracy, privacy practices, or the products and services they offer.
All content on this site — text, design, layout, methodology, scoring framework — is the property of GLP Agonists unless otherwise indicated. You may share excerpts with attribution and a link back to the original source, but reproduction of substantial portions for commercial purposes requires written permission.
We may update these terms from time to time. The "Last updated" date at the top of this page reflects the most recent revision. Continued use of the site after material changes constitutes acceptance of the revised terms.
These terms are governed by the laws of the United States and the State of California. Any disputes arising from these terms or your use of the site will be resolved in the state or federal courts located in California.
Questions about these terms: glpagonists@gmail.com.